SEC Form 4 · accession 0001209191-15-028366
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George W Mahaffey
Officer — President and CEO · Director
Period of report
Mar 19, 2015
Accepted (ET)
Mar 20, 2015 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 19, 2015 | P | 1,000 | $7.7569 | A | 197,721 | D |
Table II — derivative securities
No Table II lines on this filing.